The CD6 scavenger receptor is differentially expressed on a CD56 dim natural killer cell subpopulation and contributes to natural killer-derived cytokine and chemokine secretion

Journal of Innate Immunity

Volumn 3, Issue 4, 2011, Pages 420-434

  Braun, Monika ^a,b   Müller, Bernadette ^b,c   Ter Meer, Dominik ^d   Raffegerst, Silke ^d   Simm, Barbara ^b   Wilde, Susanne ^d   Spranger, Stefani ^d   Ellwart, Joachim ^d   Mosetter, Barbara ^d   Umansky, Ludmila ^b,c   Lerchl, Tina ^b,c   Schendel, Dolores J ^d   Falk, Christine S ^b,c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

CD6; Chemokines; Cytokines; Natural killer cells; Natural killer subpopulations; Scavenger receptor

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; CD16 ANTIGEN; CD27 ANTIGEN; CD56 ANTIGEN; CD6 ANTIGEN; CD94 ANTIGEN; CELL SURFACE MARKER; COLONY STIMULATING FACTOR 1; CXCL1 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 8; L SELECTIN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MESSENGER RNA; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; RANTES; SCAVENGER RECEPTOR; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL MIGRATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; DEGRANULATION; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NUCLEOTIDE SEQUENCE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIGENS, CD; ANTIGENS, CD56; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELL DIFFERENTIATION; CHEMOKINE CXCL1; CHEMOKINE CXCL10; CHEMOKINES; CYTOKINES; HUMANS; INTERFERON-GAMMA; KILLER CELLS, NATURAL; RECEPTORS, SCAVENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79959642979     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000322720     Document Type: Article

References (29)

1. Gregoire C, Chasson L, Luci C, Tomasello E, Geissmann F, Vivier E, Walzer T: The trafficking of natural killer cells. Immunol Rev 2007; 220: 169-182.
2. Cooper MA, Fehniger TA, Caligiuri MA: The biology of human natural killer-cell subsets. Trends Immunol 2001; 22:633-640.
3. Anfossi N, Andre P, Guia S, Falk CS, Roetynck S, Stewart CA, Breso V, Frassati C, Reviron D, Middleton D, Romagne F, Ugolini S, Vivier E: Hu man NK cell educ ation by inhibitory receptors for MHC class I. Immunity 2006; 25:331-342.
4. dim cells: role of contact with peripheral fibroblasts. J Immunol 2007; 179:89-94.
5. dim NK cells upon activation. J Immunol 2007; 178:4947-4955.
6. +high stage and effector functions. J Immunol 2004; 172:88-96.
7. dim human NK cell subsets. Blood 2010; 115:274-281.
8. Singer NG, Richardson BC, Powers D, Hooper F, Lialios F, Endres J, Bott CM, Fox DA: Role of the CD6 glycoprotein in antigen-specific and autoreactive responses of cloned human T lymphocytes. Immunology 1996; 88: 537-543.
9. Aruffo A, Bowen MA, Patel DD, Haynes BF, Starling GC, Gebe JA, Bajorath J: CD6-ligand interactions: a paradigm for SRCR domain function? Immunol Today 1997; 18: 498-504.
10. Koopman LA, Kopcow HD, Rybalov B, Boyson JE, Orange JS, Schatz F, Masch R, Lockwood CJ, Schachter AD, Park PJ, Strominger JL: Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potentia l. J Exp Med 2003; 198: 1201-1212.
11. Vossen MT, Matmati M, Hertoghs KM, Baars PA, Gent MR, Leclercq G, Hamann J, Kuijpers TW, van Lier RA: CD27 defines phenotypically and functionally different human NK cell subsets. J Immunol 2008; 180: 3739-3745.
12. dim natural killer cell subsets. J Immunol 1998; 161:400-408.
13. dim NK cells. Blood 2010; 116:1299-1307.
14. Ulbrecht M, Maier S, Hofmeister V, Falk CS, Brooks AG, McMaster MT, Weiss EH: Truncated HLA-G isoforms are retained in the endoplasmic reticulum and insufficiently provide HLA-E ligands. Hum Immunol 2004; 65:200-208.
15. Falk CS, Mach M, Schendel DJ, Weiss EH, Hilgert I, Hahn G: NK cell activity during human cytomegalovirus infection is dominated by US2-11-mediated HLA class I down-regulation. J Immunol 2002; 169: 3257-3266.
16. von Geldern M, Simm B, Braun M, Weiss EH, Schendel DJ, Falk CS: TCR-independent cytokine stimulation induces non-MHC-rest ricted T cell activity and is negatively regulated by HLA class I. Eur J Immunol 2006; 36: 2347-2358.
17. Lebbink RJ, de Ruiter T, Adelmeijer J, Brenkman AB, van Helvoort JM, Koch M, Farndale RW, Lisman T, Sonnenberg A, Lenting PJ, Meyaard L: Collagens are functional, high affinity ligands for the inhibitory immune receptor LAIR-1. J Exp Med 2006; 203:1419-1425.
18. Vitale M, Bottino C, Sivori S, Sanseverino L, Castriconi R, Marcenaro E, Augugliaro R, Moretta L, Moretta A: NKP44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J Exp Med 1998; 187:2065-2072.
19. Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari MC, Biassoni R, Moretta L: Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 2001; 19: 197-223.
20. + NK cell subset. Blood 2010; 116:3865-3874.
21. dim NK cell differentiation uncoupled from NK cell education. Blood 2010; 116: 3853-3864.
22. Castro MA, Oliveira MI, Nunes RJ, Fabre S, Barbosa R, Peixoto A, Brown MH, Parnes JR, Bismuth G, Moreira A, Rocha B, Carmo AM: Extracellular isoforms of CD6 generated by alternative splicing regulate targeting of CD6 to the immunological synapse. J Immunol 2007; 178:4351-4361.
23. Bowen MA, Whitney GS, Neubauer M, Starling GC, Palmer D, Zhang J, Nowak NJ, Shows TB, Aruffo A: Structure and chromosomal location of the human CD6 gene: detection of five human CD6 isoforms. J Immunol 1997; 158:1149-1156.
24. Alonso R, Huerta V, de Leon J, Piedra P, Puchades Y, Guirola O, Chinea G, Montero E: Towards the definition of a chimpanzee and human conserved CD6 domain 1 epitope recognized by T1 monoclonal antibody. Hybridoma (Larchmt) 2008; 27:291-301.
25. Cayrol R, Wosik K, Berard JL, Dodelet-Devillers A, Ifergan I, Kebir H, Haqqani AS, Kreymborg K, Krug S, Moumdjian R, Bouthillier A, Becher B, Arbour N, David S, Stanimirovic D, Prat A: Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system. Nat Immunol 2008; 9: 137-145.
26. Valiante NM, Uhrberg M, Shilling HG, Lienert-Weidenbach K, Arnett KL, D'Andrea A, Phillips JH, Lanier LL, Parham P: Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 1997; 7: 739-751.
27. Rosshart S, Hofmann M, Schweier O, Pfaff AK, Yoshimoto K, Takeuchi T, Molnar E, Schamel WW, Pircher H: Interaction of KLRG1 with E-cadherin: new functional and structural insights. Eur J Immunol 2008; 38: 3354-3364.
28. Nagler A, Lanier LL, Cwirla S, Phillips JH: Comparative studies of human FcRIII-positive and negative natural killer cells. J Immunol 1989; 143: 3183-3191.
29. Braud VM, Allan DS, O'Callaghan CA, Soderstrom K, D'Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL, McMichael AJ: HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998; 391: 795-799. (Pubitemid 28099678)